Ad26.COV2.S and SARS-CoV-2 spike protein ferritin nanoparticle vaccine protect against SARS-CoV-2 Omicron BA.5 challenge in macaques

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines demonstrate reduced protection against acquisition of BA.5 subvariant but are still effective against severe disease. However, immune correlates of protection against BA.5 remain unknown. We report the immunogenicity and protectiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Jingyou, Thomas, Paul V., Sciacca, Michaela, Wu, Cindy, Liu, Jinyan, He, Xuan, Miller, Jessica, Hachmann, Nicole P., Surve, Nehalee, McMahan, Katherine, Jacob-Dolan, Catherine, Powers, Olivia, Hall, Kevin, Barrett, Julia, Hope, David, Mazurek, Camille R., Murdza, Tetyana, Chang, William C., Golub, Emily, Rees, Phyllis A., Peterson, Caroline E., Hajduczki, Agnes, Chen, Wei-Hung, Martinez, Elizabeth J., Hussin, Elizabeth, Lange, Camille, Gong, Hua, Matyas, Gary R., Rao, Mangala, Suthar, Mehul, Boursiquot, Mona, Cook, Anthony, Pessaint, Laurent, Lewis, Mark G., Andersen, Hanne, Bolton, Diane L., Michael, Nelson L., Joyce, M. Gordon, Modjarrad, Kayvon, Barouch, Dan H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10040355/
https://www.ncbi.nlm.nih.gov/pubmed/37023746
http://dx.doi.org/10.1016/j.xcrm.2023.101018

Ejemplares similares

Ejemplares similares